Oncoinvent ASA (KLDVK) — Cash Flow-to-Debt Ratio
Oncoinvent ASA (KLDVK) has a Cash Flow-to-Debt Ratio of 0.02x as of December 2025, meaning its operating cash flow of Nkr3.64 Million could theoretically repay 0% of its total liabilities (Nkr230.30 Million) in one year. Check KLDVK capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncoinvent ASA Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Oncoinvent ASA across 5 annual periods. Also explore how large is Oncoinvent ASA's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oncoinvent ASA (2021–2025)
Year-by-year debt coverage analysis for Oncoinvent ASA. For market capitalisation and broader financial context, see Oncoinvent ASA stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | Nkr-23.24 Million | Nkr230.30 Million | ▼ -46.0% |
| 2024 | -0.07x | Nkr-14.84 Million | Nkr214.71 Million | ▲ +75.3% |
| 2023 | -0.28x | Nkr-40.23 Million | Nkr143.77 Million | ▼ -9065.0% |
| 2022 | 0.00x | Nkr373.06K | Nkr119.51 Million | ▲ +41.6% |
| 2021 | 0.00x | Nkr130.66K | Nkr59.25 Million | — |